$CGON insider trading
Over the last 12 months, CG Oncology insiders reported 2 buys totaling $74.8M and 17 sales totaling $6.6M across SEC Form 4 filings. 100% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $74.8M 2 events
- Sold · 12m
- $6.6M 17 events
- Events · 12m
- 19 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | POST LEONARD ED | ▼ Sale | 1,000 | $74.54 | $75K | -100% | plan |
| Jul 15, 2026 | POST LEONARD ED | ▼ Sale | 1,000 | $71.17 | $71K | -100% | plan |
| Jul 10, 2026 | Mulay JamesD | ▼ Sale | 24,165 | $75.16 | $1.8M | -100% | plan |
| Jun 25, 2026 | Liu Brian Guan-ChyunD | ▲ Buy | 371,085 | $66.87 | $24.8M | +24.5% | plan · indirect |
| Jun 24, 2026 | POST LEONARD ED | ▼ Sale | 5,000 | $70 | $350K | -100% | plan |
| Jun 22, 2026 | POST LEONARD ED | ▼ Sale | 5,000 | $65 | $325K | -100% | plan |
| Jun 15, 2026 | Mulay JamesD | ▼ Sale | 1,964 | $60.12 | $118K | -100% | plan · 2 tranches |
| Jun 4, 2026 | POST LEONARD ED | ▼ Sale | 1,000 | $54.5 | $55K | -100% | plan |
| Apr 17, 2026 | Mulay JamesD | ▼ Sale | 15,600 | $73.01 | $1.1M | -100% | plan |
| Mar 16, 2026 | Mulay JamesD | ▼ Sale | 1,964 | $63.5 | $125K | -100% | plan · 2 tranches |
| Jan 9, 2026 | Mulay JamesD | ▼ Sale | 11,145 | $52.47 | $585K | -100% | plan · 2 tranches |
| Nov 17, 2025 | POST LEONARD ED | ▼ Sale | 1,000 | $41.43 | $41K | -100% | plan |
| Oct 13, 2025 | POST LEONARD ED | ▼ Sale | 1,000 | $43.25 | $43K | -100% | plan |
| Oct 9, 2025 | Mulay JamesD | ▼ Sale | 5,903 | $43.99 | $260K | -100% | plan |
| Sep 30, 2025 | POST LEONARD ED | ▼ Sale | 5,000 | $40.09 | $200K | -100% | plan |
| Sep 29, 2025 | Mulay JamesD | ▼ Sale | 12,755 | $39.19 | $500K | -100% | plan |
| Sep 19, 2025 | Mulay JamesD | ▼ Sale | 22,686 | $39.01 | $885K | -100% | plan · 2 tranches |
| Sep 15, 2025 | POST LEONARD ED | ▼ Sale | 1,000 | $35.1 | $35K | -100% | plan |
| Sep 11, 2025 | Liu Brian Guan-ChyunD | ▲ Buy | 1,515,151 | $33 | $50.0M | — | plan · indirect |
| Sep 5, 2025 | Mulay JamesD | ▼ Sale | 27,015 | $31.53 | $852K | -100% | plan · 4 tranches |
| Sep 3, 2025 | Song Hong FangD | ▼ Sale | 100,000 | $27.8 | $2.8M | -3.3% | plan · 4 tranches · indirect |
| Sep 3, 2025 | POST LEONARD ED | ▼ Sale | 1,000 | $28 | $28K | -100% | plan |
Every $CGON filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? CG Oncology filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CGON feed.